Last updated on July 2019

Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)


Brief description of study

The purpose of this study is to initially access the safety and effectivity of RC18 combined with standard treatment and Placebo combined with standard therapy in subjects with Moderate to severe SLE, Besides ,to provide dose basis for follow-up clinical trials.

Clinical Study Identifier: NCT02885610

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.